A new way to see
precision health
We deliver advanced imaging solutions that can help doctors make better decisions, personalize care for patients, and ensure better outcomes.
Unmatched, integrated data intelligence
Conventional diagnostics give you one-dimensional, incomplete insights in black and white. 海角社区鈥檚 proprietary technology gives you a fuller picture 鈥 extracting biomarkers from imaging in an intuitive and streamlined way, which can lead to better diagnoses and outcomes.
Discover 海角社区
at the USA Pavilion
Safe, streamlined, and
accessible
Safe, streamlined, and accessible
海角社区鈥檚 imaging solutions are safe, fast, and can offer more comprehensive diagnostics. We help doctors understand complex data and help deliver precision care to more patients.
OUR PRODUCTS 鉄Patient-first
approach
Patient-first
approach
We believe the voice of the patient matters and that each case is unique. Our goal is to enable healthcare providers to tailor precision medicine to the needs of the individual.
FOR PATIENTS 鉄Proven leadership in
healthcare
Proven leadership in
healthcare
Our approach to patient care draws on the expertise of the renowned physicians and scientists who lead our company.
OUR COMPANY 鉄2024 PrixGalien USA Nominee
CoverScan, 海角社区鈥檚 multi-organ MRI technology, has been nominated for the award for Best Digital Health Solution. 海角社区 is among nominees who have been recognized for "extraordinary dedication to innovation鈥 to advance patient care. Winners will be announced during the Prix Galien USA Forum on November 7, 2024, at the Alexandria Center for Life Science in New York City.
Resources
For Patients
Everyone and every case is unique. By focusing on customized solutions that deliver better outcomes, we can help build a kinder healthcare system.
For Healthcare Professionals
Our patented non-invasive technology extracts actionable information from imaging in an intuitive and streamlined way, which can result in faster diagnoses and better outcomes.
For Researchers
We collaborate with world-leading experts to accelerate research on metabolic diseases, cancer, diabetes, and other chronic diseases.
In the news
July 8, 2025
Marea Therapeutics Publishes Phase 2 Trial Results in The Lancet
May 7, 2025
Major Study Shows Liver Health Measured with cT1 Predicts Clinical Outcomes
March 18, 2025
New Multinational Study Shows MRI is Cost-Effective in the Diagnosis and Management of Steatotic Liver Disease